PIM
MRNA icon

Platinum Investment Management’s Moderna MRNA Stock Holding History

Platinum Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-18,193
Closed -$2.16M – 140
2024
Q2 		$2.16M Sell
18,193
-5,380
-23% -$681K 0.09% 64
2024
Q1 		$2.51M Sell
23,573
-57,679
-71% -$5.81M 0.1% 67
2023
Q4 		$8.08M Sell
81,252
-84
-0.1% -$7.07K 0.33% 44
2023
Q3 		$8.4M Buy
81,336
+43,210
+113% +$4.82M 0.33% 38
2023
Q2 		$4.63M Hold
38,126
– – 0.16% 58
2023
Q1 		$5.86M Buy
38,126
+17,626
+86% +$2.91M 0.2% 51
2022
Q4 		$3.68M Buy
+20,500
New +$3.35M 0.14% 60
2022
Q1 		– Sell
-19,230
Closed -$4.88M – 145
2021
Q4 		$4.88M Buy
+19,230
New +$5.62M 0.14% 63
2021
Q1 		– Sell
-11,207
Closed -$1.17M – 149
2020
Q4 		$1.17M Sell
11,207
-7,321
-40% -$741K 0.03% 108
2020
Q3 		$1.31M Sell
18,528
-12,532
-40% -$874K 0.03% 99
2020
Q2 		$1.99M Sell
31,060
-1,504,855
-98% -$82.4M 0.05% 86
2020
Q1 		$46M Buy
1,535,915
+83,443
+6% +$1.92M 1.16% 27
2019
Q4 		$28.4M Sell
1,452,472
-18,537
-1% -$329K 0.56% 31
2019
Q3 		$23.4M Sell
1,471,009
-11,536
-0.8% -$170K 0.52% 30
2019
Q2 		$21.7M Buy
1,482,545
+8,669
+0.6% +$186K 0.51% 30
2019
Q1 		$30M Sell
1,473,876
-3,251
-0.2% -$60.3K 0.71% 30
2018
Q4 		$22.6M Buy
+1,477,127
New +$24.3M 0.76% 25

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Platinum Investment Management's MRNA Position: Q3 2024 in Review

Platinum Investment Management sold out of Moderna (MRNA) in Q3 2024, closing a stake of 18,193 shares — an estimated $2.16M sold.

Platinum Investment Management first reported a position in MRNA in Q4 2018 and held it in 17 quarters. The position peaked at $46M in Q1 2020. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Platinum Investment Management reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Platinum Investment Management sold 18,193 Moderna shares in Q3 2024, an estimated $2.16M.
  • Platinum Investment Management first reported a position in Moderna in Q4 2018 and held it in 17 quarters.
  • Platinum Investment Management's Moderna position peaked at $46M in Q1 2020.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Platinum Investment Management's 13F filing for Q3 2024, filed 8 Nov 2024.